“…For example, lower P3 is also seen in other disorders, i.e., depression (Bruder et al, 2012;Klawohn et al, 2020), schizophrenia (Qiu et al, 2014), bipolar (Wada et al, 2019), attention deficit/hyper-activity (Kaiser et al, 2020), autism (Cui et al, 2017), psychopathy (Gao and Raine, 2009), panic (Howe et al, 2014), and Alzheimer's (Hedges et al, 2016), suggesting that P3 may be a trans-diagnostic factor (i.e., not specific to SUD) related to deficits in P3-associated attentional, working memory, and behavioral updating processes. Similarly, there is evidence for beta as a transdiagnostic rather than SUD-specific factor, as suggested by higher beta in insomnia , psychosocial stress (Vanhollebeke et al, 2022), and Parkinson's (Cagnan et al, 2019), and dysregulated (or decreased) beta in externalizing disorder (Rudo-Hutt, 2015), traumatic brain injury (Allen et al, 2021) and epilepsy (Dharan et al, 2021). In addition, theta deserves more research attention, as it is (like beta) a heritable marker of AUD (Meyers et al, 2021), involved with working memory and executive control (Cavanagh and Frank, 2014), and a well-studied biomarker in depression (Jamieson et al, 2022) and schizophrenia (Hirano and Uhlhaas, 2021).…”